Kelly Goldsmith named co-leader of DDT Program at Winship

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Kelly C. Goldsmith, a physician-scientist specializing in pediatric oncology, has been named co-leader of the Discovery and Developmental Therapeutics Program, one of four research programs within Winship Cancer Institute of Emory University.

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

People of African ancestry (Black/African American) have some of the worst cancer incidence and greatest mortality, compared to white and other racial and ethnic populations in the U.S. On average, Black persons are 1.5 times more likely to have cancer and >2X more likely to die from cancer compared to whites. xxx:more

Login